*LILLY'S SOLANEZUMAB DIDN'T MEET PRIMARY ENDPOINT IN TRIAL
Alerts: HALISTER, HALISTER1
Source: BN (Bloomberg News)
Tickers
LLY US (Eli Lilly & Co)
People
David Ricks (Eli Lilly & Co)
Jan Lundberg (Eli Lilly & Co)
John Lechleiter (Eli Lilly & Co)
Philip Johnson (Eli Lilly & Co)
To de-activate the "HALISTER" alert, click here
To modify this alert, click here
To de-activate the "HALISTER1" alert, click here
To modify this alert, click here
UUID: 7947283
Alerts: HALISTER, HALISTER1
Source: BN (Bloomberg News)
Tickers
LLY US (Eli Lilly & Co)
People
David Ricks (Eli Lilly & Co)
Jan Lundberg (Eli Lilly & Co)
John Lechleiter (Eli Lilly & Co)
Philip Johnson (Eli Lilly & Co)
To de-activate the "HALISTER" alert, click here
To modify this alert, click here
To de-activate the "HALISTER1" alert, click here
To modify this alert, click here
UUID: 7947283